Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Glaxo to reap $890M as it halves stake in South Africa's Aspen
Glaxo to reap $890M as it halves stake in South Africa's Aspen
Glaxo to reap $890M as it halves stake in South Africa's Aspen
Submitted by
admin
on March 12, 2015 - 9:37pm
Source:
Fierce Biotech
News Tags:
GSK
Aspen
South Africa
Headline:
Glaxo to reap $890M as it halves stake in South Africa's Aspen
Do Not Allow Advertisers to Use My Personal information
